Verve Therapeutics
VERV
#6544
Rank
C$0.74 B
Marketcap
$8.78
Share price
-0.79%
Change (1 day)
-60.37%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -C$0.31 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are C$20.64 Million. In 2023 the company made an earning of -C$0.32 Billion a decrease over its 2022 earnings that were of -C$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.31 Billion-3.25%
2023 -C$0.32 Billion34.67%
2022 -C$0.24 Billion90.3%
2021 -C$0.13 Billion114.31%
2020 -C$56.51 Million